Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy

Figure 10

The relationship between IL-17 concentration, clinical parameters, and five-year survival of OC patients.

(a)

(b)

(c)

(d)

(e)

(f)